
NuScale Power Faces March Selloff as Analysts Reassess Growth Timeline
NuScale stock fell 15.6% in March after disappointing Q4 earnings, prompting analyst downgrades. Revenue declined 15% to $31.5M, but 2030 commercialization timeline remains on track.
SMRGSGSpAGSpCGSpD+4stock declineearnings miss














